Verona Pharma (NASDAQ:VRNA) Price Target Raised to $72.00
Verona Pharma (NASDAQ:VRNA – Free Report) had its price target hoisted by Canaccord Genuity Group from $44.00 to $72.00 in a research note published on Wednesday,Benzinga reports. They currently have a buy rating on the stock. A number of other research analysts have also recently weighed in on VRNA. HC Wainwright reaffirmed a “buy” rating […]
Verona Pharma (NASDAQ:VRNA – Free Report) had its price target hoisted by Canaccord Genuity Group from $44.00 to $72.00 in a research note published on Wednesday,Benzinga reports. They currently have a buy rating on the stock. A number of other research analysts have also recently weighed in on VRNA. HC Wainwright reaffirmed a “buy” rating […]
